191 related articles for article (PubMed ID: 32321766)
1. Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer.
Davra V; Saleh T; Geng K; Kimani S; Mehta D; Kasikara C; Smith B; Colangelo NW; Ciccarelli B; Li H; Azzam EI; Kalodimos CG; Birge RB; Kumar S
Mol Cancer Res; 2020 Aug; 18(8):1189-1201. PubMed ID: 32321766
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.
Saleh T; Jankowski W; Sriram G; Rossi P; Shah S; Lee KB; Cruz LA; Rodriguez AJ; Birge RB; Kalodimos CG
Nat Chem Biol; 2016 Feb; 12(2):117-23. PubMed ID: 26656091
[TBL] [Abstract][Full Text] [Related]
3. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
[TBL] [Abstract][Full Text] [Related]
4. Immunophilins control T lymphocyte adhesion and migration by regulating CrkII binding to C3G.
Nath PR; Dong G; Braiman A; Isakov N
J Immunol; 2014 Oct; 193(8):3966-77. PubMed ID: 25225668
[TBL] [Abstract][Full Text] [Related]
5. In vivo regulation of human CrkII by cyclophilin A and FK506-binding protein.
Nath PR; Dong G; Braiman A; Isakov N
Biochem Biophys Res Commun; 2016 Feb; 470(2):411-416. PubMed ID: 26792730
[TBL] [Abstract][Full Text] [Related]
6. Crk Tyrosine Phosphorylation Regulates PDGF-BB-inducible Src Activation and Breast Tumorigenicity and Metastasis.
Kumar S; Lu B; Davra V; Hornbeck P; Machida K; Birge RB
Mol Cancer Res; 2018 Jan; 16(1):173-183. PubMed ID: 28974561
[TBL] [Abstract][Full Text] [Related]
7. Prolyl cis-trans Isomerization as a molecular timer in Crk signaling.
Nicholson LK; Lu KP
Mol Cell; 2007 Feb; 25(4):483-5. PubMed ID: 17317620
[TBL] [Abstract][Full Text] [Related]
8. The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.
Solbak SM; Reksten TR; Wray V; Bruns K; Horvli O; Raae AJ; Henklein P; Henklein P; Röder R; Mitzner D; Schubert U; Fossen T
BMC Struct Biol; 2010 Oct; 10():31. PubMed ID: 20920334
[TBL] [Abstract][Full Text] [Related]
9. Crk adaptor proteins regulate CD3ζ chain phosphorylation and TCR/CD3 down-modulation in activated T cells.
Dong G; Kalifa R; Nath PR; Babichev Y; Gelkop S; Isakov N
Cell Signal; 2017 Aug; 36():117-126. PubMed ID: 28465009
[TBL] [Abstract][Full Text] [Related]
10. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
[TBL] [Abstract][Full Text] [Related]
11. A new twist to adaptor proteins contributes to regulation of lymphocyte cell signaling.
Isakov N
Trends Immunol; 2008 Aug; 29(8):388-96. PubMed ID: 18599349
[TBL] [Abstract][Full Text] [Related]
12. Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration.
Watanabe T; Tsuda M; Makino Y; Konstantinou T; Nishihara H; Majima T; Minami A; Feller SM; Tanaka S
Cell Res; 2009 May; 19(5):638-50. PubMed ID: 19350053
[TBL] [Abstract][Full Text] [Related]
13. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.
Zheng J; Koblinski JE; Dutson LV; Feeney YB; Clevenger CV
Cancer Res; 2008 Oct; 68(19):7769-78. PubMed ID: 18829531
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
[TBL] [Abstract][Full Text] [Related]
15. Abl functions as a negative regulator of Met-induced cell motility via phosphorylation of the adapter protein CrkII.
Cipres A; Abassi YA; Vuori K
Cell Signal; 2007 Aug; 19(8):1662-70. PubMed ID: 17399949
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
Ptak RG; Gallay PA; Jochmans D; Halestrap AP; Ruegg UT; Pallansch LA; Bobardt MD; de Béthune MP; Neyts J; De Clercq E; Dumont JM; Scalfaro P; Besseghir K; Wenger RM; Rosenwirth B
Antimicrob Agents Chemother; 2008 Apr; 52(4):1302-17. PubMed ID: 18212100
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.
Qian Z; Zhao X; Jiang M; Jia W; Zhang C; Wang Y; Li B; Yue W
BMC Cancer; 2012 Oct; 12():442. PubMed ID: 23031673
[TBL] [Abstract][Full Text] [Related]
18. Adaptor protein CRK induces epithelial-mesenchymal transition and metastasis of bladder cancer cells through HGF/c-Met feedback loop.
Matsumoto R; Tsuda M; Wang L; Maishi N; Abe T; Kimura T; Tanino M; Nishihara H; Hida K; Ohba Y; Shinohara N; Nonomura K; Tanaka S
Cancer Sci; 2015 Jun; 106(6):709-717. PubMed ID: 25816892
[TBL] [Abstract][Full Text] [Related]
19. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
20. Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer.
Kumar S; Davra V; Obr AE; Geng K; Wood TL; De Lorenzo MS; Birge RB
Oncoimmunology; 2017; 7(1):e1376155. PubMed ID: 29296536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
